Cubist Systematic Strategies’s Syneron Medical Ltd ELOS Stock Holding History

Cubist Systematic Strategies’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-54,100	Closed	-$592K	–	2146
2017 Q2	$592K	Buy	54,100 +13,948	+35%	+$153K	0.04%	665
2017 Q1	$424K	Buy	+40,152	New	+$388K	0.03%	731
2015 Q2	–	Sell	-32,126	Closed	-$398K	–	2193
2015 Q1	$398K	Buy	+32,126	New	+$356K	0.02%	1083
2014 Q4	–	Sell	-6,177	Closed	-$62K	–	2153
2014 Q3	$62K	Buy	+6,177	New	+$62.8K	﹤0.01%	1614

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Cubist Systematic Strategies's ELOS Position: Q3 2017 in Review

Cubist Systematic Strategies sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 54,100 shares — an estimated $592K sold.

Cubist Systematic Strategies first reported a position in ELOS in Q3 2014 and held it in 4 quarters. The position peaked at $592K in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

Cubist Systematic Strategies reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
Cubist Systematic Strategies sold 54,100 Syneron Medical Ltd shares in Q3 2017, an estimated $592K.
Cubist Systematic Strategies first reported a position in Syneron Medical Ltd in Q3 2014 and held it in 4 quarters.
Cubist Systematic Strategies's Syneron Medical Ltd position peaked at $592K in Q2 2017.
4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Cubist Systematic Strategies's 13F filing for Q3 2017, filed 14 Nov 2017.